PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
337,500
+5,500 (1.66%)
Mar 28, 2025, 3:30 PM KST
238.18%
Market Cap 3.51T
Revenue (ttm) 350.12B
Net Income (ttm) 92.04B
Shares Out 10.39M
EPS (ttm) 8,940.87
PE Ratio 37.75
Forward PE 26.32
Dividend 1,100.00 (0.33%)
Ex-Dividend Date Dec 27, 2024
Volume 43,132
Average Volume 86,372
Open 334,500
Previous Close 332,000
Day's Range 327,000 - 337,500
52-Week Range 98,600 - 345,000
Beta 0.53
RSI 61.79
Earnings Date May 9, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.